Literature DB >> 16416601

Expression of cystatin C in clinical human colorectal cancer tissues.

Yousif Saleh1, Tadeusz Sebzda, Maria Warwas, Wieslaw Kopec, Jolanta Ziólkowska, Maciej Siewinski.   

Abstract

We studied the relation between the antipapain activity of cysteine proteinase inhibitors (CPI) and immunohistochemical staining for cystatin C, using anti-chicken cystatin antibodies, in the colorectal cancer tissues. In primary tumour tissues immuno-peroxidase reactivity was present in the cytoplasm and on the cell surface membranes. Sections of non malignant tissues showed no staining. The percentages of positive staining were greater for adenocarcinoma than carcinoma,100% and 77% respectively. Antipapain activity which was increased in malignant tissues in comparison to control, rose successively from well differentiated carcinomas through moderately to poor differentiated. Invasive adenocarcinomas had higher antipapain activity than noninvasive ones. The results indicated that immunohistochemical detection of cystatin using anti-chicken cystatin antibodies could be useful in studying the prognostic significance of cystatin C expression in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16416601

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  10 in total

1.  Prognostic value of cystatin C in patients with nasopharyngeal carcinoma: a retrospective study of 1063 patients.

Authors:  Jing Yuan; Miao Xu; Jing Li; Ning Li; Li-Zhen Chen; Qi-Sheng Feng; Yi-Xin Zeng
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

2.  Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.

Authors:  Da-Nian Dai; Yan Li; Bo Chen; Yong Du; Shi-Bing Li; Shi-Xun Lu; Zhi-Ping Zhao; Ai-Jun Zhou; Ning Xue; Tian-Liang Xia; Mu-Sheng Zeng; Qian Zhong; Wei-Dong Wei
Journal:  J Mol Med (Berl)       Date:  2017-05-18       Impact factor: 4.599

3.  Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis.

Authors:  Xinkui Liu; Jiarui Wu; Dan Zhang; Zhitong Bing; Jinhui Tian; Mengwei Ni; Xiaomeng Zhang; Ziqi Meng; Shuyu Liu
Journal:  Front Genet       Date:  2018-07-17       Impact factor: 4.599

4.  The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.

Authors:  Ping Tan; Ming Shi; Jie Chen; Hang Xu; Nan Xie; Huan Xu; Yong Jiang; Jian-Zhong Ai; Liang-Ren Liu; Lu Yang; Qiang Wei
Journal:  Asian J Androl       Date:  2019 Mar-Apr       Impact factor: 3.285

5.  Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis.

Authors:  Aiping Tian; Ke Pu; Boxuan Li; Min Li; Xiaoguang Liu; Liping Gao; Xiaorong Mao
Journal:  Hepatol Res       Date:  2019-07-16       Impact factor: 4.288

6.  Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures.

Authors:  Inayatullah Shaikh; Afzal Ansari; Garima Ayachit; Monika Gandhi; Priyanka Sharma; Shivarudrappa Bhairappanavar; Chaitanya G Joshi; Jayashankar Das
Journal:  Oncotarget       Date:  2019-10-22

7.  Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer.

Authors:  Haocheng Wang; Dongfeng Shan; Ya Dong; Xue Yang; Linwei Zhang; Zhuang Yu
Journal:  Oncol Lett       Date:  2020-11-25       Impact factor: 2.967

8.  Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer.

Authors:  Yan Yan; Kun Zhou; Liping Wang; Feng Wang; Xinfeng Chen; Qingxia Fan
Journal:  Onco Targets Ther       Date:  2017-04-03       Impact factor: 4.147

9.  [Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer].

Authors:  Xuede Zhang; Yanli Hou; Zequn Niu; Wei Li; Xia Meng; Na Zhang; Shuanying Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20

10.  Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden.

Authors:  Woo Sun Kwon; Tae Soo Kim; Chung Hyun Nahm; Yeonsook Moon; Jin Ju Kim
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.